Dr Ali Taheri
Higher Degree by Research Candidate
School of Pharmacy and Biomedical Sciences
College of Health
| Year | Citation |
|---|---|
| 2026 | Taheri, A., Bremmell, K. E., Hickey, S. M., Joyce, P., & Prestidge, C. A. (2026). Oral delivery of topoisomerase I inhibitors: From biopharmaceutical barriers to clinical translation.. Journal of controlled release : official journal of the Controlled Release Society, 115166. |
| 2025 | Subramaniam, S., Donnellan, L., Wignall, A., Woodcock, J., Coolen, C., Pitson, S., . . . Joyce, P. (2025). Polymeric-lipid nanoparticles that leverage cationic helper lipids and the protein corona for lung-targeted delivery of a novel anti-cancer drug. Journal of Controlled Release, 388(Pt 1), 114299. Scopus5 WoS5 Europe PMC2 |
| 2025 | Taheri, A., Almasri, R., Wignall, A., Feltrin, F., Bremmell, K. E., Joyce, P., & Prestidge, C. A. (2025). Enteric coating enhances the Biopharmaceutical performance of a silica-lipid formulation of Abiraterone Acetate. Pharmaceutics, 17(10, article no. 1289), 1-12. |
| 2024 | Taheri, A., Almasri, R., Wignall, A., Schultz, H. B., Elz, A. S., Ariaee, A., . . . Prestidge, C. A. (2024). Enhancing the pharmacokinetics of abiraterone acetate through lipid-based formulations: addressing solubility and food effect challenges. Drug Delivery and Translational Research, online(11), 3770-3782. Scopus5 WoS6 Europe PMC2 |
| 2023 | Taheri, A., Bremmell, K. E., Joyce, P., & Prestidge, C. A. (2023). Battle of the milky way: lymphatic targeted drug delivery for pathogen eradication. Journal of Controlled Release, 363, 507-524. Scopus15 WoS10 Europe PMC8 |
| 2023 | Tabarsi, P., Anjidani, N., Shahpari, R., Mardani, M., Sabzvari, A., Yazdani, B., . . . Barati, S. (2023). Evaluating the efficacy and safety of SpikoGen?, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial. CLINICAL MICROBIOLOGY AND INFECTION, 29(2), 215-220. WoS38 Europe PMC37 |
| 2022 | Tabarsi, P., Anjidani, N., Shahpari, R., Mardani, M., Sabzvari, A., Yazdani, B., . . . Barati, S. (2022). Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations. CLINICAL MICROBIOLOGY AND INFECTION, 28(9), 1263-1271. WoS40 Europe PMC42 |
| 2022 | Rezaei, S., Taheri, A., Taheri, S., Kasirzadeh, S., Fatemi, B., & Sorato, M. M. (2022). Efficacy and safety of insulin detemir versus glargine in patients with diabetes: a systematic review and meta-analysis. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 15(6), 767-777. WoS3 Europe PMC3 |
| 2021 | Kasirzadeh, S., Ghahremani, M. H., Setayesh, N., Jeivad, F., Shadboorestan, A., Taheri, A., . . . Sabzevari, O. (2021). β-Sitosterol Alters the Inflammatory Response in CLP Rat Model of Sepsis by Modulation of NFκB Signaling. BIOMED RESEARCH INTERNATIONAL, 2021(1), 11 pages. WoS31 Europe PMC27 |
| 2021 | Rezaei, S., Fatemi, B., Karimi Majd, Z., Minaei, H., Peikanpour, M., Anjidani, N., . . . Mosaed, R. (2021). Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 17(5), 499-511. WoS23 Europe PMC22 |
| 2019 | Taheri, A., Emami, M., Asadipour, E., Kasirzadeh, S., Rouini, M. -R., Najafi, A., . . . Mojtahedzadeh, M. (2019). A randomized controlled trial on the efficacy, safety, and pharmacokinetics of metformin in severe traumatic brain injury. JOURNAL OF NEUROLOGY, 266(8), 1988-1997. WoS31 Europe PMC26 |
| 2018 | Taheri, A., Lavasani, H., Kasirzadeh, S., Sheikholeslami, B., Ardakani, Y. H., & Rouini, M. -R. (2018). Changes in CYP2D enzyme activity following induction of type 2 diabetes, and administration of cinnamon and metformin: an experimental animal study. XENOBIOTICA, 48(10), 984-989. WoS7 Europe PMC5 |
Courses I teach
- PUBH 3008 UO Epidemiological Principles and Methods (2026)
- MATH 1065 Quantitative Methods in Health (2025)
- PHAR 2014 Dosage Form Design 1 (2025)
- PHAR 2014 Dosage Form Design 1 (2024)
- PHAR 2016 Dosage Form Design 2 (2024)